Stroke Bricks — spatial brain regions to assess ischaemic stroke localisation
Abstract
Computer-aided analysis of non-contrast computed tomography (NCCT) images for rapid diagnosis of ischaemic stroke is based on the augmented visualisation of evolving ischaemic lesions. Computerised support of NCCT often leads to overinterpretation of ischaemic areas, thus it is of great interest to provide neurologically verified regions in order to improve accuracy of subsequent radiological assessment. We propose Stroke Bricks (StBr) as an arbitrary spatial division of brain tissue into the regions associated with specific clinical symptoms of ischaemic stroke. Neurological stroke deficit is formally translated into respective areas of possible ischaemic lesions. StBr were designed according to formalised mapping of neurological symptoms and were attributed to the uniquely defined areas of impaired blood supply. StBr concept may be useful for an integrated radiological CT-based assessment of suspected stroke cases or can be included into computer-aided tools to optimise the evaluation of stroke site and its extent. These data in turn are appropriable for further diagnosis, predicting the therapeutic outcome as well as for patients’ qualification for an appropriate form of reperfusion therapy. The usefulness of StBr was illustrated in the case studies.
Keywords: cerebral arteriesstrokeischaemic strokebrain ischaemiacerebral haemorrhagecomputed tomography
References
- Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000; 355(9216): 1670–1674.
- Blackburn K, Labranche L, Kalmey J, et al. A case of a single intracranial vertebral artery and cerebral infarct. Folia Morphologica. 2017; 76(1): 134–138.
- Ebinger M, Kunz A, Wendt M, et al. Effects of golden hour thrombolysis: a prehospital acute neurological treatment and optimization of medical care in stroke (PHANTOM-S) substudy. JAMA Neurol. 2015; 72(1): 25–30.
- El-Koussy M, Schroth G, Brekenfeld C, et al. Imaging of acute ischemic stroke. Eur Neurol. 2014; 72(5-6): 309–316.
- Heit JJ, Wintermark M. Imaging selection for reperfusion therapy in acute ischemic stroke. Curr Treat Options Neurol. 2015; 17(2): 332.
- Sandercock P, Wardlaw JM, Lindley RI, et al. IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012; 379(9834): 2352–2363.
- Przelaskowski A, Sobieszczuk E, Jóźwiak R, et al. Integrated System for Clinical Decision Support in Emergency Stroke Care. Info Technol Med. 2016: 457–473.
- Rorden C, Bonilha L, Fridriksson J, et al. Age-specific CT and MRI templates for spatial normalization. Neuroimage. 2012; 61(4): 957–965.
- Szarmach A, Winklewski PJ, Halena G, et al. Morphometric evaluation of the delayed cerebral arteries response to acetazolamide test in patients with chronic carotid artery stenosis using computed tomography angiography. Folia Morphol. 2017; 76(1): 10–14.
- Wardlaw J, Murray V, Berge E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012; 379(9834): 2364–2372.
- Wardlaw J, Murray V, Berge E, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014; 29(7): CD000213.
![](https://journals.viamedica.pl/plugins/generic/popups/images/icons/close.png)